Pomalyst (Pomalidomide) Capsules
Generic name : Pomalidomide.
Trade name : Pomalyst.
Manufacturer information :
Pomalyst is manufactured by Celgene Corporation.
Pomalyst FDA Approval :
Pomalyst first approved February 8th, 2013.
Pomalyst Dosage form :
Capsules: 1 mg, 2 mg, 3 mg, and 4 mg.
Pomalyst Indications and Usage :
Thalidomide analogue, in combination with dexamethasone, is indicated for multiple myeloma in patients who have received at least 2 prior therapies (including lenalidomide and a proteasome inhibitor) and have disease progression on or within 60 days of completion of the last therapy.
Pomalyst (Pomalidomide) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.